Allergy & Immunology

Filter

Rilzabrutinib Offers Hope for Patients with Refractory Urticaria

April 2025

The RILECSU phase 2 clinical trial has introduced a potential new option: rilzabrutinib.

Urine Samples Used to Detect Bladder Cancer

SCIENTISTS have developed a non-invasive bisulphite sequencing test to detect bladder cancer using urine samples that matches the performance of a…

Introducing EMJ Innovations 1.1

United Kingdom, January 10, 2017: Happy new year and welcome to our first journal of the year, the inaugural edition of the European Medical Journal…

Low Levels of Physical Activity Can Still Improve Happiness

THE RESULTS of a large study that used the smartphones of over 10,000 participants show that small amounts of physical activity, or non-exercise activity…

Long-Term Eczema May be Triggered by Immune System Over-reaction

MATHEMATICAL MODELLING has been used to study how atopic dermatitis (AD), the most common form of eczema, progresses. A team of researchers from Imperial…

New Cavity Treatment Allows Tooth to Repair Itself

SCIENTISTS from the Dental Institute at King’s College London, London, UK, have reported a way to stimulate stem cell renewal as a new tooth repair…

EMJ

EAACI Celebrates 60 Years of Influencing Policy and Medical Practice in Europe and Beyond

Florence, 10 November 2016 – The European Academy of Allergy and Clinical Immunology (EAACI) celebrates today in Florence 60 years of successful…

Introducing EMJ Hematology 4.1

United Kingdom, July 28, 2016: Welcome to EMJ Hematology. This edition provides a wide selection of peer-reviewed articles exploring the emerging issues…

Merck Commits €1.5 million to the Grant for Fertility Innovation (GFI) for 2016/17

Darmstadt, Germany, July 06, 2016 – Merck, a leading science and technology company, today announced it would continue to support the advancement of…

Loading posts...

« Previous 1 … 23 24 25 26 27 Next »